Related Experiment Videos

Lipid testing and lipid-lowering therapy in hospitalized ischemic stroke and transient ischemic attack patients:

Andrew J Mullard1, Mathew J Reeves, Bradley S Jacobs

  • 1Department of Epidemiology, Michigan State University, East Lansing, MI 48824, USA.

Stroke
|December 13, 2005
PubMed

Insights

Many stroke survivors do not receive recommended lipid-lowering therapy (LLT) during hospitalization. Significant gaps exist in lipid testing and LLT initiation, highlighting the need for quality improvement initiatives.

Area of Science:

  • Neurology
  • Cardiology
  • Public Health

Background:

  • Recent guidelines advocate for initiating lipid-lowering therapy (LLT) in most ischemic stroke (IS) and transient ischemic attack (TIA) survivors during hospitalization.
  • However, current practices regarding in-hospital lipid testing and LLT initiation for these patients are not well-documented.

Purpose of the Study:

  • To describe the utilization of in-hospital lipid testing and LLT among IS and TIA survivors.
  • To identify predictors associated with receiving lipid testing and LLT during hospitalization.

Main Methods:

  • The study utilized data from a statewide stroke registry, including IS and TIA cases discharged alive from a stratified sample of 16 hospitals in 2002.
  • A total of 1907 patients were analyzed for LLT use at admission, and 1399 patients not on LLT at admission were assessed for lipid testing and discharge LLT.

Main Results:

  • Only 30.2% of patients were on LLT at admission. Among those not on LLT, 37.2% underwent lipid testing, and 12.9% received LLT at discharge.
  • Significant variations in testing and LLT use were observed across hospitals. Predictors for testing included teaching hospitals and neurologist/neurosurgeon involvement, while older age, female sex, atrial fibrillation, nonambulatory status, and poor prognosis were negatively associated.
  • LLT at discharge was associated with prior dyslipidemia, lipid testing, and elevated LDL levels. Critically, only 31.2% of patients with clear indications for LLT received it at discharge.

Conclusions:

  • A substantial proportion of hospitalized IS and TIA patients with indications for LLT remain untreated upon discharge.
  • Addressing these treatment gaps requires focused quality improvement efforts, particularly for high-risk patient populations.
  • Improving lipid evaluation and subsequent treatment initiation is crucial for secondary stroke prevention.
Abstract

Related Concept Videos

Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.